Alltracel Pharmaceuticals

Alltracel Pharmaceuticals was an Irish medical technology company that specialized in the development and commercialization of bioactive materials for wound care and cardiovascular health. The company's flagship technology, m.doc (micro-dispersed oxidized cellulose), is a proprietary hemostatic agent derived from cotton that rapidly stops bleeding by accelerating the natural clotting process. Alltracel successfully integrated this technology into a variety of consumer and professional products, including nasal plugs, bandages, and sprays. The company operated primarily through a licensing model, partnering with major global healthcare brands to incorporate its technology into their product lines. In 2008, Alltracel was acquired by the US-based HemCon Medical Technologies to expand their combined portfolio of wound care solutions.